Navigation Links
CPhI South America Gains Traction
Date:10/11/2011

AMSTERDAM, Oct. 11, 2011 /PRNewswire/ -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced post-show details of CPhI South America which took place from 24–26 August at the Transamerica Expo Center in Sao Paulo, Brazil. Now in its fifth year, the pharmaceutical ingredients event attracted nearly 4,000 visits and more than 180 exhibitors which offered a high return on investment to both visitors and exhibitors, who were able to meet existing customers or suppliers and make new contacts in one convenient location.

"We are delighted that CPhI South America continues to gain traction in the South American market," says Annemieke Timmers, Global Brand Director. "South America is an increasingly important part of the global pharmaceutical market, and we believe the event is an invaluable way for South American and international companies to network and generate new business. As we build the brands in this region, we will continue to work to provide a comprehensive programme that will prove to offer growth to our attendees, as well."

The newest introduction was a structured Conference Series that attracted 150 senior level delegates from laboratories, government and API suppliers. The programme was opened by Dirceu Barbano, Director-President of the Brazilian government pharmaceutical authority ANVISA, and featured Presidents and Chief Executives from the country's most important laboratories and pharma associations. The biosimilars module proved particularly popular with delegates, highlighting the great market potential of these products for the future.

Popular returning features to CPhI South America included the ICSE Pavilion and the BioPh Trail. The ICSE Pavilion offered a dedicated area within the exhibition hall for companies whose business focuses on contract services and clinical trials. These sectors have proven increasingly important within the South American market, as growing numbers of multinational pharmaceutical companies are expanding their businesses within South America, and carrying out clinical trials there. The BioPh Trail was formatted to offer targeted biotechnology resources and enable small biotech and big pharma players to connect with each other.

In 2012, CPhI South America will return to the Transamerica Expo Center in Sao Paulo from 21–23 August. To learn more about CPhI South America and to register for attendance for free, please visit: www.cphi-sa.com.

UBM Lives' market leading schedule of co-located annual events include CPhI India (30 November - 2 December, 2011, Bombay Exhibition Centre, Mumbai), Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Center, Japan), China (26-28 June, 2012, SNIEC, Shanghai, China), and CPhI Worldwide (9-11 October, 2012, Feria de Madrid, Spain).

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.


'/>"/>
SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
2. Bluestar Silicones Moves Forward with Growth Plans; Completes Acquisition of Facility in South Carolina
3. Pinnacle Biologics Appoints ALKOPHARMA SA Its Exclusive Distributor For PDT (Photodynamic Therapy), in Select European Countries, Middle East And South East Asian Territories
4. South and Central America Cardiovascular Devices Market Outlook to 2017
5. Orthopedic Accessories Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
6. External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
7. Ampio Pharmaceuticals Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane™ in South Korea
8. Hillcrest Completes Purchase of SouthCrest & Claremore Hospitals
9. Cardium to Present at Southern California Investor Conference
10. Life Extension® Announces Recruitment for Alzheimers Clinical Trial in South Florida
11. Innovative Dialysis Systems, Inc., Announces Opening of Four New Dialysis Facilities in Southern California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):